India’s medical technology sector received a significant boost with the launch of a dedicated investment platform focused on supporting the country’s growing medical device ecosystem. The MedTech Capital fund has been introduced through a partnership between Andhra Pradesh MedTech Zone (AMTZ) and MedArtha Capital, with the aim of strengthening innovation, research and manufacturing in the sector.
The initiative was unveiled in Mumbai by Union Minister for Commerce and Industry Piyush Goyal. The new platform will provide growth capital as well as strategic guidance to emerging medical device companies, helping them scale operations, advance product development and strengthen manufacturing capabilities within India. The fund is designed to support entrepreneurs working in the medical technology space by connecting capital with specialised industry expertise and manufacturing infrastructure. By doing so, the initiative aims to accelerate the development of globally competitive medical device companies originating from India.
Speaking at the launch, the Union Minister described the medical technology industry as one of the country’s most promising emerging sectors. He pointed to India’s expanding talent base and growing awareness of preventive healthcare as key drivers that could support the sector’s growth in the coming years.
The minister noted that platforms that connect innovation with investment are essential for enabling startups to scale their technologies and expand research capabilities. Such initiatives, he said, help strengthen the entire medical technology value chain while supporting the development of new healthcare solutions.
Ganesh Sabat, Managing Partner of MedArtha Capital, explained that building globally competitive medical technology companies requires more than just funding. According to him, entrepreneurs also need access to domain expertise and specialised manufacturing ecosystems such as the infrastructure available at AMTZ. He described MedArtha Capital as an operator-led investment platform that works closely with founders and management teams to help build medical device companies capable of competing in international markets. The platform aims to combine financial investment with operational experience to accelerate the growth of high-potential companies.
Dr Jitendra Sharma, Managing Director and Founder Chief Executive Officer of AMTZ, highlighted the innovation emerging from Indian medical technology entrepreneurs. He said that platforms such as the new fund can play a crucial role in nurturing the next generation of global MedTech companies from India. According to Dr Sharma, the country possesses strong engineering talent, clinical expertise and cost-efficient manufacturing capabilities. Together, these strengths provide a strong foundation for developing globally competitive medical devices and healthcare technologies.
The launch event also included a panel discussion focused on the future of India’s medical technology ecosystem. Participants discussed the importance of collaboration between investors, entrepreneurs, manufacturers and policymakers in building a robust domestic MedTech industry. The session was moderated by journalist Niraj Shah and included industry participants such as Swati Bansal from the National Investment and Infrastructure Fund, Bhargav Kotadia, Managing Director and Chief Executive Officer of SMT, and Abhishek Kabra, Managing Director at Samara Capital.
Panelists emphasised the need for coordinated efforts across the investment community, healthcare innovators and manufacturing stakeholders to support the growth of India’s medical device sector. As global demand for advanced healthcare technologies continues to rise, India is increasingly seen as a potential hub for high-quality and cost-effective medical devices.
By combining capital investment with infrastructure and technical expertise, initiatives such as the MedTech Capital fund aim to strengthen domestic manufacturing while reducing reliance on imports. The new platform is expected to support the development of companies that can address healthcare needs both within India and in international markets. By nurturing innovation and enabling access to capital, the initiative seeks to position India as an important contributor to the global medical technology industry in the years ahead.
